TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Oncothyreon: Why I'm Buying Back In VFC submits: In March I announced that I had sold all of my position in Oncothyreon (ONTY) after information became public that Merck KGaA (MRK), ONTY's partner for the clinical development of Stimuvax, had halted all trials of the product after a patient had contracted encephalitis in one of the trials.Stimuvax is one of the new breed of cancer 'vaccines' being tested in multiple common forms of cancer, including breast and lung cancer.Complete Story » seekingalpha.com |
Charles River Investors Kill WuXi Deal The Burrill Report submits: By Marie DaghlianCharles River Laboratories (CRL) and WuXi PharmaTech (WX) terminated their acquisition agreement due to investor opposition by Jana Partners, Charles River’s largest shareholder. The contract research organization giant will pay WuXi a $30 million breakup fee as a result. Complete Story » seekingalpha.com |
Genoptix: Magic Formula Stock or Magic Value Trap? Gaurav Sharma submits:Looks like a good value stock.......now let's find out if its a trap.As of 07/30/2010 the stock has fallen 56% from its high.Cash = $140 M = 7.7$/shareMarket Cap = 300M = 17.19/shareFCF for 2009 = 30, 2008 = 22,2007 = 12.5Has had tremendous growth in the past.Does out of clinic blood evaluation and suggests treatments. Currently, oncologists are being squeezed. They are being paid the same amount even though costs are rising and hence they are looking to reduce expenses. Also, uninsured patients are increasing. Besides that competition is increasing as described below.Complete Story » seekingalpha.com |
FDA to Revoke Knee-Device Approval The FDA said it planned to revoke a medical-device company's right to sell a knee implant called Menaflex after an unprecedented yearlong review concluded the agency erred in allowing it on the market. online.wsj.com |
Ice on Fire! - Video New Survey Shows Real-World Activities Can Help Reinvigorate Student Interest in Science Education feedproxy.google.com |